ANDBIOTECH
DEAD

Serial Number

98729925

Owner

AND BIOTECH LTD

Attorney

Jason Paul Blair

Filing Date

Sep 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ANDBIOTECH Trademark

Serial Number: 98729925

ANDBIOTECH is a trademark filed by AND BIOTECH LTD on September 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AND BIOTECH LTD

Weena 240, Tower C, 9th Floor
Rotterdam 3012NJ , NL

Entity Type: 16

Trademark Details

Filing Date

September 3, 2024

Registration Date

Not Registered

Published for Opposition

July 22, 2025

Goods & Services

Preparations for destroying dry rot fungus; media for bacteriological cultures; bacteriological culture mediums; capsules for medicines; prescribed and over-the-counter (OTC) chemico-pharmaceutical preparations for the treatment of respiratory, autoimmune, gastrological, circulatory, neurological, oncological, dermatological, musculoskeletal, ocular, and infectious diseases; vitamin preparations; medicine for alleviating constipation; vaccines; digestives for pharmaceutical purposes; prescribed and over-the-counter (OTC) drugs for medical purposes for the treatment of respiratory, autoimmune, gastrological, circulatory, neurological, oncological, dermatological, musculoskeletal, ocular, and infectious diseases; meal for pharmaceutical purposes; lacteal flour for babies; prescribed and over-the-counter (OTC) medicinal infusions for the treatment of respiratory, autoimmune, gastrological, circulatory, neurological, oncological, dermatological, musculoskeletal, ocular, and infectious diseases; medicinal tea; medicinal oils, other than essential oils for medical purposes; yeast for pharmaceutical purposes; cultures for microorganisms for medical or veterinary use; pastilles for pharmaceutical purposes; prescribed and over-the-counter (OTC) ointments for pharmaceutical purposes for the treatment of respiratory, autoimmune, gastrological, circulatory, neurological, oncological, dermatological, musculoskeletal, ocular, and infectious diseases; pharmaceutical preparations for skin care; Phosphates for pharmaceutical purposes; Chemical preparations for treating phylloxera; Quinine for medical purposes; Sulfonamide preparations; Dietetic foods adapted for medical purposes; Food for babies; Biological preparations for medical purposes; Dietetic beverages adapted for medical purposes; Royal jelly for pharmaceutical purposes; Medicines for dental purposes; prescribed and over-the-counter (OTC) medicines for human purposes for the treatment of respiratory, autoimmune, gastrological, circulatory, neurological, oncological, dermatological, musculoskeletal, ocular, and infectious diseases; Medicinal drinks; Ferments for pharmaceutical purposes; Dietetic substances adapted for medical use; Chemical preparations for medical purposes; Dietary fiber; Enzymes for medical purposes; Amino acids for medical purposes; Disinfectants for chemical toilets; Fish meal for pharmaceutical purposes; Mineral food supplements; Mouthwashes for medical purposes; Nutritional supplements; Antibiotics; Appetite suppressants for medical purposes; Adjuvants for medical purposes; Biological tissue cultures for medical purposes; Medicated eye-washes; Yeast dietary supplements; Royal jelly dietary supplements; Enzyme dietary supplements; Alginate dietary supplements; Alginates for pharmaceutical purposes; Protein dietary supplements; Infant formula; Powdered milk for babies; Collagen for medical purposes; Pharmaceuticals; Preparations of microorganisms for medical or veterinary use; Immunostimulants; Nutraceutical preparations for therapeutic or medical purposes; Freeze-dried food adapted for medical purposes; Antibacterial soap; Antibacterial handwashes; Dietary supplements with a cosmetic effect; Capsules made of dendrimer-based polymers, for pharmaceuticals; Chemical preparations for treating diseases affecting cereal plants; Medicated toothpaste; Whey protein dietary supplements; Brewer's yeast dietary supplements; Dietary supplements for human beings

Chemical analysis; Bacteriological research; Chemistry services, namely, chemical laboratories and chemical engineering; Chemical research; Biological research; Scientific research in the field of environmental protection; Scientific research; Scientific research in the nature of conducting clinical trials for others; Medical research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 20, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 20, 2026 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 18, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 18, 2025 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 19, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 19, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 19, 2025 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 22, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 1, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 1, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 1, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 1, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 1, 2025 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 13, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2025 NWOS
NEW APPLICATION ENTERED
Sep 3, 2024 NWAP